Antenatal Betamethasone for Women at Risk for Late Preterm Delivery Article Swipe

PDF

Related Concepts

medicine betamethasone bronchopulmonary dysplasia relative risk chorioamnionitis gestation antenatal steroid gestational age anesthesia pregnancy fraction of inspired oxygen randomized controlled trial continuous positive airway pressure placebo obstetrics confidence interval mechanical ventilation surgery internal medicine alternative medicine biology pathology genetics obstructive sleep apnea

Cynthia Gyamfi-Bannerman , Elizabeth Thom , Sean C. Blackwell , Alan Tita , Uma M. Reddy , George R. Saade , Dwight J. Rouse , David S. McKenna , Erin Clark , John M. Thorp , Edward K. Chien , Alan M. Peaceman , Ronald S. Gibbs , Geeta K. Swamy , Mary E. Norton , Brian M. Casey , Steve N. Caritis , Jorge E. Tolosa , Yoram Sorokin , J. Peter VanDorsten , Lucky Jain ·

YOU? · · 2016 · Open Access · · DOI: https://doi.org/10.1056/nejmoa1516783 · OA: W2321364247

Administration of betamethasone to women at risk for late preterm delivery significantly reduced the rate of neonatal respiratory complications. (Funded by the National Heart, Lung, and Blood Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; ClinicalTrials.gov number, NCT01222247.).